Ontecizumab Uses, Dosage, Side Effects and more
Ontecizumab is under investigation in clinical trial NCT01574716 (Sarcoma Study of Morab-004 Utilization: Research and Clinical Evaluation).
| Trade Name | Ontecizumab |
| Generic | Ontuxizumab |
| Ontuxizumab Other Names | Ontecizumab, Ontuxizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
